Optimization of Real-Time PCR Conditions for COVID-19 Diagnosis with Logix Smart Reagent™
Abstract
Corona Virus Disease 2019 or COVID-19 is a new type of virus that attacks the respiratory tract and can cause death. Laboratory examinations play an essential role in diagnosing COVID-19 with a set of reagents or kits. Sampiand sampling is carried out with a nasopharyngeal swab or oropharyngeal swab. Positive samples of COVID-19 patients used in this study were converted into RNA at the COVID-19 Referral Clinic in Bekasi, after which volume optimization was carried out with a total volume of 5 µl, 8 µl, and 10 µl with the Logix Smart™ kit. The method in this study uses One-Step Real-time PCR. This method is the best method for carrying out several bear tests because it can reduce the possibility of sample contamination. The procedure is fast and has high sensitivity. The fluorescence detection used in this study was FAM with a specific target of COVID-19 RNA and ROX with a particular DNA target of RNase-P. This research was conducted to obtain optimal volume conditions under the manufacturer's standards in detecting the SARS-CoV-2 virus. The results of this study indicate that a total volume of 5 l is the optimal total volume for detecting the presence of the SARS- CoV-2 virus in samples taken from patients.
References
Chan, J. F. W., Yuan, S., Kok, K. H., To, K. K. W., Chu, H., Yang, J., Xing, F., Liu, J., Yip, C. C. Y., Poon, R. W. S., Tsoi, H. W., Lo, S. K. F., Chan, K. H., Poon, V. K. M., Chan, W. M., Ip, J. D., Cai, J. P., Cheng, V. C. C., Chen, H., … Yuen, K. Y. (2020). A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. The Lancet, 395(10223), 514–523. https://doi.org/10.1016/S0140-6736(20)30154-9
Co-Diagnostics Inc. (2020). Logix Smart TM Coronavirus Disease 2019 (COVID-19) Kit. 2019(March), 21.
Dramé, M., Tabue Teguo, M., Proye, E., Hequet, F., Hentzien, M., Kanagaratnam, L., & Godaert, L. (2020). Should RT-PCR be considered a gold standard in the diagnosis of COVID-19? Journal of Medical Virology, 92(11), 2312–2313. https://doi.org/10.1002/jmv.25996
Ember, K., Daoust, F., Mahfoud, M., Dallaire, F., Ahmad, E. Z., Tran, T., Plante, A., Diop, M.-K., Nguyen, T., St-Georges-Robillard, A., Ksantini, N., Lanthier, J., Filiatrault, A., Sheehy, G., Beaudoin, G., Quach, C., Trudel, D., & Leblond, F. (2022). Saliva-based detection of COVID-19 infection in a real-world setting using reagent-free Raman spectroscopy and machine learning. Journal of Biomedical Optics, 27(02), 1–24. https://doi.org/10.1117/1.jbo.27.2.025002
Harcourt, J., Tamin, A., Lu, X., Kamili, S., Kumar, S., Murray, J., Queen, K., Tao, Y., Paden, C., Zhang, J., Uehara, A., Wang, H., Goldsmith, C., Bullock, H., Wang, L., Whitaker, B., Lynch, B., Gautam, R., Schindewolf, C., … Thornburg, N. (2020). Isolation and characterization of SARS-CoV-2 from the first us COVID-19. Bio Rxiv, 114(June), e00146. https://doi.org/10.1016/j.sciaf.2019.e00146
Hou, T., Zeng, W., Yang, M., Chen, W., Ren, L., Ai, J., Wu, J., Liao, Y., Gou, X., Li, Y., Wang, X., Su, H., Gu, B., Wang, J., & Xu, T. (2020). Development and evaluation of a rapid CRISPR-based diagnostic for COVID-19. PLoS Pathogens, 16(8), 1–12. https://doi.org/10.1371/journal.ppat.1008705
Kobayashi, R., Murai, R., Asanuma, K., Fujiya, Y., & Takahashi, S. (2021). Evaluating a novel, highly sensitive, and quantitative reagent for detecting SARS-CoV-2 antigen. Journal of Infection and Chemotherapy, 27(6), 800–807. https://doi.org/10.1016/j.jiac.2021.01.007
Santini, A. (2021). Optimising the assignment of swabs and reagent for PCR testing during a viral epidemic. Omega (United Kingdom), 102, 102341. https://doi.org/10.1016/j.omega.2020.102341
Setiati, S., & Azwar, M. K. (2020). COVID-19 and Indonesia. April.
Singh, A. K., Nema, R. K., Joshi, A., Shankar, P., Gupta, S., Yadav, A. K., Nema, S., Mathew, B. J., Shrivas, A., Patankar, C., Raghuwanshi, A., Pandey, R., Tripathi, R., Ansari, K., Singh, K., Yadav, J., Biswas, D., & Singh, S. (2021). Testing of four-sample pools offers resource optimization without compromising diagnostic performance of real time reverse transcriptase-PCR assay for COVID-19. PLoS ONE, 16(5 May), 1–10. https://doi.org/10.1371/journal.pone.0251891
Tahamtan, A., & Ardebili, A. (2020). Real-time RT-PCR in COVID-19 detection: issues affecting the results. Expert Review of Molecular Diagnostics, 20(5), 453–454. https://doi.org/10.1080/14737159.2020.1757437
Valitutto, M. T., Aung, O., Tun, K. Y. N., Vodzak, M. E., Zimmerman, D., Yu, J. H., Win, Y. T., Maw, M. T., Thein, W. Z., Win, H. H., Dhanota, J., Ontiveros, V., Smith, B., Tremeau-Brevard, A., Goldstein, T., Johnson, C. K., Murray, S., & Mazet, J. (2020). Detection of novel coronaviruses in bats in Myanmar. PLoS ONE, 15(4), 1–11. https://doi.org/10.1371/journal.pone.0230802
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.